McKechnie Duncan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，McKechnie Duncan（CIK 2062139）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-07-07）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-07 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 1,541 | $799,779 |
| 2026-03-13 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 2,633 | $1.3M |
| 2026-03-06 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 2,437 | $1.2M |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 873 | $423,501 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 2,500 | $1.2M |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 2,410 | $1.2M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 买入 | 4,962 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 1,148 | $555,345 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 2,283 | $1.1M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 卖出 | 1,127 | $527,898 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 买入 | 4,720 | $0 |
| 2026-01-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Commercial Officer | 买入 | 2,080 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-07